Stop Atherosclerosis in Native Diabetics Study


Phase 4 Results

Summary of Purpose

Compared to standard treatment goals achieving lower targets for LDL cholesterol (bad cholesterol) and blood pressure in people with diabetes will slow the progression of atherosclerosis as measured by carotid artery thickness, and reduce clinical cardiovascular events such as heart attacks and strokes. This study is a randomized 3-year trial. The primary endpoint will be a combination of various measures of the...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 October 2006.

1 May 2003 2 Sep 2005 Unavailable 1 May 2007 1 Sep 2005 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available